Katsumori T, Fujita M, Takahashi T, Satoh O, Ichijima S, Nakamura T, Morishita H, Ohno K, Nakano Y, Maeda T
Department of Radiology, Kyoto Prefectural University of Medicine, Japan.
Cardiovasc Intervent Radiol. 1995 Jul-Aug;18(4):217-21. doi: 10.1007/BF00239415.
Evaluate therapeutic results of transcatheter segmental hepatic artery chemo-oily-embolization (segmental TAE) against advanced hepatocellular carcinomas (HCC) accompanied by portal tumor thrombus (PTT).
Segmental TAE was performed in nine patients with hepatic cirrhosis and advanced HCCs accompanied by PTT. Four subsegmental portal branches were obstructed by PTT in three patients, and two were obstructed in the remaining six patients. TAE was performed into the targeted segmental hepatic artery followed by embolization with gelatin sponge particles.
In one patient undergoing subsequent resection, a marked anticancer effect on the PTT was demonstrated histologically. In the eight other patients who did not undergo subsequent resection, the cumulative survival rates were 67% at 6 months, 44% at 1 year, and 22% at 2 years. No serious complications were noted.
This therapeutic approach is thought to be a useful treatment for HCC with PTT, because it reinforces anticancer effects and can be performed more safely than conventional transcatheter arterial embolization.
评估经导管节段性肝动脉化疗油性栓塞术(节段性TAE)治疗伴有门静脉癌栓(PTT)的晚期肝细胞癌(HCC)的疗效。
对9例肝硬化合并伴有PTT的晚期HCC患者实施节段性TAE。3例患者的4个亚段门静脉分支被PTT阻塞,其余6例患者有2个亚段门静脉分支被阻塞。在靶向节段性肝动脉内进行TAE,随后用明胶海绵颗粒栓塞。
1例接受后续切除术的患者,组织学检查显示对PTT有显著的抗癌效果。其他8例未接受后续切除术的患者,6个月时的累积生存率为67%,1年时为44%,2年时为22%。未观察到严重并发症。
这种治疗方法被认为是治疗伴有PTT的HCC的一种有效治疗方法,因为它增强了抗癌效果,并且比传统的经导管动脉栓塞术更安全。